✦ LIBER ✦

Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry

✍ Scribed by Ying Guo; Jennifer Tisoncik; Susanna McReynolds; Michael Farzan; Bellur S. Prabhakar; Thomas Gallagher; Lijun Rong; Michael Caffrey

Book ID: 116664324
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 426 KB
Volume: 394
Category: Article
ISSN: 0022-2836
DOI: 10.1016/j.jmb.2009.10.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of critical determinants

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor

✍ Dong P. Han; Adam Penn-Nicholson; Michael W. Cho 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 800 KB

Development of a Cell-Based Assay for Id

Development of a Cell-Based Assay for Identification of Viral Entry Inhibitors Against SARS-CoV by High Throughput Screening (HTS)

✍ Chengsheng Zhang; Yan Feng; Gillian Wong; Liping Wang; Jonathan Cechetto; Jan Bl 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Design of recombinant protein-based SARS

Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain

✍ Ling Ni; Jieqing Zhu; Junjie Zhang; Meng Yan; George F. Gao; Po Tien 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Monoclonal antibodies to SARS-associated

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

✍ Ralph A. Tripp; Lia M. Haynes; Deborah Moore; Barbara Anderson; Azaibi Tamin; Br 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Evaluation of a recombinant nucleocapsid

Evaluation of a recombinant nucleocapsid protein-based assay for Anti-SARS-CoV IgG detection

✍ Paul K.S. Chan; Esther Y.M. Liu; Danny T.M. Leung; Jo L.K. Cheung; C.H. Ma; Fran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract A high throughput accurate assay for anti‐SARS‐CoV IgG detection is needed for large‐scale epidemiological studies. The evaluation of a commercial recombinant nucleocapsid protein‐based microtitre plate enzyme immunoassay, ELISARS™ is described. The results on 150 sera from SARS patient

SARS-CoV nucleocapsid protein antagonize

SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism

✍ Xiaolu Lu; Ji’an Pan; Jiali Tao; Deyin Guo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 550 KB